PAA 2.56% 20.0¢ pharmaust limited

Ann: OLE Study update reveals impressive Survival Data, page-196

  1. 31 Posts.
    lightbulb Created with Sketch. 14
    My thoughts as well ..
    we demanded a board that works in the best interest of shareholders. this is that BoD now so I am pretty certain they would not go against that mandate by doing a capital raising at these low levels , especially without trying to get our SP back to at least where the previous team had us. Otherwise what was the point of the board spill ??

    I am placing my trust in them that we will get a very positive funding announcement . If not then that’s when we ask serious questions,, until then we relax and wait patiently. We (well most) have the luxury to be a bit more patient ,, MND sufferers do not so let’s get this P2/3 trial commencing without delay .!
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.